Isodiol International Inc (ISOLF)

[MarketProphet]

Isodiol International takes major sponsorship role at the NY Cannabis World Congress & Business Expo
LAGBF, C.ISOL, ISOL | 17 hours ago

Canada NewsWire
VANCOUVER, June 14, 2017
VANCOUVER, June 14, 2017 /CNW/ - Isodiol International Inc.- (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the "Company" or "Isodiol") a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce we are one of the key sponsors at the NY Cannabis World Congress & Business Expo this June 14-16.
This annual cannabis business event is held at the Jacob K. Javits Convention Center in NY and is the leading forum for doing business in one of the fastest growing industries in the United States. 
"Isodiol is also honored to have Dr. Ron Aung-Din, a neurologist with over 35 years of experience in General Neurology and Neuro-Psychiatry, speaking about the positive benefits and advancements of phytocannabinoids and presenting IsoDerm, a premium product he developed along with the team at Isodiol," said Isodiol's CEO Marcos Agramont.
"Sponsoring this event along with having Dr. Ron Aung-Din present at the seminar, gives Isodiol key exposer to play an active roll in our industry and meet with global vendors and investors to speak firsthand with them about what we believe, which is, we are at the start of significant global operational highlights that will give our company a very strong foundation for customer engagement and retention, while accelerating Isodiol's pace of innovation and competitive differentiation moving forward, with our brands like CBD Naturals, Iso-Sport, CannaCeuticals CBD Skincream, and Pot-O-Coffee," said Agramont. 
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol's nutraceutical division is the pioneer of many firsts for Hemp-derived cannabidiol (CBD), including 99% pure crystalline isolate, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.
ON BEHALF OF THE BOARD
"Marcos Agramont"
CEO & Director

Read more at http://www.stockhouse.com/news/press-releases/2017/06/14/isodiol-international-takes-major-sponsorship-role-at-the-ny-cannabis-world#H07TH7UIGMQkQFOW.99